Applications of (S)-4-Phenyl-1,3-Thiazolidine-2-Thione in Industrial Manufacturing

(S)-4-Phenyl-1,3-Thiazolidine-2-Thione provides specialized functionalities as a chiral intermediate within several advanced industrial production streams. As a chemical manufacturer, we have enabled our clients to adapt this compound in applications requiring high enantioselectivity, strict compliance to international quality standards, and reliable integration into multistep synthesis. Below, we detail principal downstream sectors making real industrial use of this material, emphasizing critical technical requirements for each application scenario.

1. Chiral Pharmaceutical API Synthesis

Our material supports pharmaceutical companies in asymmetric synthesis of specific active pharmaceutical ingredients, especially those requiring thiazolidine-derived frameworks. In these production settings, process chemists employ this raw material for the enantioselective construction of molecular scaffolds relevant in cardiovascular and central nervous system drug candidates. We ensure lot-to-lot consistency to meet stringent regulatory filings for commercial-scale pharmaceutical launches where traceability and purity analytics are mandatory.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) monographs
• US Pharmacopoeia (USP) General Chapters
• FDA cGMP 21 CFR 210/211 for API production

Typical usage ratio

• Employed at 0.3%–2.5% w/w relative to target API, with adjustments made for pathway-specific conversion rates and enantiomeric excess requirements

Downstream process integration

• Introduced during key enantioselective step following initial ring formation, purified by chiral chromatography in intermediate purification, and traced through to final stage coupling

Final product types

• Chemically synthesized small molecule APIs (e.g., thiazolidinone-based drugs)
• Regulated pharmaceutical intermediates submitted in global DMFs

2. Fine Chemical Intermediate for Agrochemical Actives

Major agrochemical formulators select this intermediate for the production of sulfur- and thiazolidine-containing crop protection agents, utilizing its reactivity to generate bioactive thio-substituted compounds. Our product helps downstream producers achieve uniform structure-activity performance for advanced fungicides and herbicides. Trace metal and organic purity are certified to support registration dossiers for internationally traded agricultural chemicals.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 9001:2015 Quality Management Systems for chemical processing
• REACH Regulation (EC) No 1907/2006 for EU marketability

Typical usage ratio

• Applied at 1.0%–3.5% w/w, ratio set based on the precursor-to-product conversion efficiency and final efficacy targets for the active ingredient

Downstream process integration

• Reacted with alkylating agents during core macrocycle assembly, then transferred through multi-step isolations to produce stable agrochemical active ingredients

Final product types

• Commercial fungicide technical concentrates
• Pre-formulated herbicide actives for field application

3. Chiral Auxiliary in Advanced Material Synthesis

Producers in the specialty materials sector integrate this compound in the stereoselective synthesis of high-value materials such as specialty polymers and optoelectronic chemicals. The chiral control provided during complex monomer assembly underpins the mechanical and photonic properties of next-generation polymeric materials. Analytical grade consistency allows for precise calibration in research and pilot-scale runs aimed at electronics and photonics manufacturing.

Industry compliance standards

• ISO 9001:2015 for materials manufacturing
• RoHS Directive 2011/65/EU for electronics precursor compliance
• Customer-supplied internal QC protocols for advanced material inputs

Typical usage ratio

• Between 0.4%–1.2% by monomer feed mass; formulation adjusted to achieve specified chirality indices and end-use property profiles

Downstream process integration

• Dosed in the enantioselective step of monomer synthesis, upstream of polymerization; removed or recycled after chirality induction depending on end-use purity requirements

Final product types

• Specialty chiral polymers for optical media
• Functionalized monomers for photonic device fabrication

4. Building Block in Peptide and Amino Acid Derivative Synthesis

Peptide and amino acid derivative manufacturers leverage this input to construct sulfur-bridged intermediates for pharmaceutical and biochemical use. Its performance in creating non-proteinogenic amino acids enriches libraries for drug screening and diagnostic reagent development. Controlled handling protocols in our facility ensure cross-contamination prevention and full trace reporting for batch-level documentation.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• USP General Chapter <1078> for Good Storage and Shipping Practices
• ISO 13485:2016 where peptides are destined for diagnostic applications

Typical usage ratio

• Ranged from 0.8%–2.0% w/w relative to peptide chain precursor, with optimization per target diastereomeric outcome and batch scale

Downstream process integration

• Introduced at the step of cyclic amino acid coupling, with subsequent deprotection and purification by preparative HPLC

Final product types

• Sulfur-bridged peptide research intermediates
• Functionalized amino acid derivatives for pharmaceutical R&D